Citations (61)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Rafael Lanaro, Débora Bressanim de Aquino Calemi, Loraine Rezende Togni, José Luiz Costa, Maurício Yonamine, Silvia de Oliveira Santos Cazenave & Alessandra Linardi. (2015) Ritualistic Use of Ayahuasca versus Street Use of Similar Substances Seized by the Police: A Key Factor Involved in the Potential for Intoxications and Overdose?. Journal of Psychoactive Drugs 47:2, pages 132-139.
Read now
Read now
Rafael Guimarães dos Santos. (2013) A Critical Evaluation of Reports Associating Ayahuasca with Life-Threatening Adverse Reactions. Journal of Psychoactive Drugs 45:2, pages 179-188.
Read now
Read now
Rafael Guimarães dos Santos. (2013) Safety and Side Effects of Ayahuasca in Humans—An Overview Focusing on Developmental Toxicology. Journal of Psychoactive Drugs 45:1, pages 68-78.
Read now
Read now
Simon L. Hill & Simon H. L. Thomas. (2011) Clinical toxicology of newer recreational drugs. Clinical Toxicology 49:8, pages 705-719.
Read now
Read now
Aslihan Yuruktumen, Sevilay Karaduman, Fecri Bengi & John Fowler. (2008) Syrian rue tea: A recipe for disaster. Clinical Toxicology 46:8, pages 749-752.
Read now
Read now
Christina Hernon, Dennis Paoloni & Michael Ganetsky. (2007) Pharmaceutical Modulation of Illicit Drug Effects. American Journal on Addictions 16:3, pages 245-246.
Read now
Read now
. (2005) Abstracts of the European Association of Poisons Centres and Clinical Toxicologists XXV International Congress. Clinical Toxicology 43:5, pages 387-538.
Read now
Read now
Articles from other publishers (54)
Andreas Halman, Geraldine Kong, Jerome Sarris & Daniel Perkins. (2023) Drug–drug interactions involving classic psychedelics: A systematic review. Journal of Psychopharmacology.
Crossref
Crossref
Raj Kishore Patra, Neha Pandey & Desul Sudarsan. (2022) Bibliometric analysis of fake news indexed in Web of Science and Scopus (2001-2020). Global Knowledge, Memory and Communication 72:6/7, pages 628-647.
Crossref
Crossref
Benjamin Malcolm & Kelan Thomas. (2021) Serotonin toxicity of serotonergic psychedelics. Psychopharmacology 239:6, pages 1881-1891.
Crossref
Crossref
Anna O Ermakova, Fiona Dunbar, James Rucker & Matthew W Johnson. (2021) A narrative synthesis of research with 5-MeO-DMT. Journal of Psychopharmacology 36:3, pages 273-294.
Crossref
Crossref
Ľuboš Nižnanský, Žofia Nižnanská, Roman Kuruc, Andrea Szórádová, Ján Šikuta & Anežka Zummerová. (2022) Ayahuasca as a Decoction Applied to Human: Analytical Methods, Pharmacology and Potential Toxic Effects. Journal of Clinical Medicine 11:4, pages 1147.
Crossref
Crossref
Eun-Joo Shin, Ji Hoon Jeong, Bao-Trong Nguyen, Naveen Sharma, Seung-Yeol Nah, Yoon Hee Chung, Yi Lee, Jae Kyung Byun, Toshitaka Nabeshima, Sung Kwon Ko & Hyoung-Chun Kim. (2021) Ginsenoside Re Protects against Serotonergic Behaviors Evoked by 2,5-Dimethoxy-4-iodo-amphetamine in Mice via Inhibition of PKCδ-Mediated Mitochondrial Dysfunction. International Journal of Molecular Sciences 22:13, pages 7219.
Crossref
Crossref
Rafael Lanaro, Sueli Moreira Mello, Kelly Francisco Cunha, Gabriela Silveira, Nelson Francisco Corrêa‐Neto, Stephen Hyslop, Oscar G. Cabrices, Jose Luiz Costa & Alessandra Linardi. (2020)
Kinetic profile of
N,N
‐dimethyltryptamine and β‐carbolines in saliva and serum after oral administration of ayahuasca in a religious context
. Drug Testing and Analysis 13:3, pages 664-678.
Crossref
Crossref
Sara Malaca, Alfredo Fabrizio Lo Faro, Alice Tamborra, Simona Pichini, Francesco Paolo Busardò & Marilyn A. Huestis. (2020) Toxicology and Analysis of Psychoactive Tryptamines. International Journal of Molecular Sciences 21:23, pages 9279.
Crossref
Crossref
Yan Shi, Roujia Wang, Shuai Yuan, Huosheng Qiang, Min Shen, Baohua Shen, Olaf H. Drummer, Zhiguo Yu, Yunli Zhao & Ping Xiang. (2020) UHPLC-MS/MS method for simultaneously detecting 16 tryptamines and their metabolites in human hair and applications to real forensics cases. Journal of Chromatography B 1159, pages 122392.
Crossref
Crossref
Máté Kapitány-Fövény, Ornella Corazza, Shanna Marrinan & Zsolt Demetrovics. 2020. The Cambridge Handbook of Substance and Behavioral Addictions. The Cambridge Handbook of Substance and Behavioral Addictions
307
325
.
. 2020. The Cambridge Handbook of Substance and Behavioral Addictions. The Cambridge Handbook of Substance and Behavioral Addictions
295
425
.
. 2020. The Cambridge Handbook of Substance and Behavioral Addictions. The Cambridge Handbook of Substance and Behavioral Addictions.
M. Rosaria Varì, Simona Pichini, Raffaele Giorgetti & Francesco P. Busardò. (2018) New psychoactive substances—Synthetic stimulants. WIREs Forensic Science 1:2.
Crossref
Crossref
Nazim A. Mamedov, Ardalan Pasdaran & Nilufer Z. Mamadalieva Mamadalieva. (2017) Pharmacological studies of Syrian rue (Peganum harmala L., Zygophyllaceae). International Journal of Secondary Metabolite, pages 1-6.
Crossref
Crossref
Robson Savoldi, Daniel Polari, Jaquelinne Pinheiro-da-Silva, Priscila F. Silva, Bruno Lobao-Soares, Mauricio Yonamine, Fulvio A. M. Freire & Ana C. Luchiari. (2017) Behavioral Changes Over Time Following Ayahuasca Exposure in Zebrafish. Frontiers in Behavioral Neuroscience 11.
Crossref
Crossref
Tomás Herraiz, Hugo Guillén, Vicente J. Arán & Antonio Salgado. (2017) Identification, occurrence and activity of quinazoline alkaloids in Peganum harmala. Food and Chemical Toxicology 103, pages 261-269.
Crossref
Crossref
Lea Wagmann, Simon D. Brandt, Pierce V. Kavanagh, Hans H. Maurer & Markus R. Meyer. (2017) In vitro monoamine oxidase inhibition potential of alpha-methyltryptamine analog new psychoactive substances for assessing possible toxic risks. Toxicology Letters 272, pages 84-93.
Crossref
Crossref
Curtis P. Snook. 2017. Critical Care Toxicology. Critical Care Toxicology
1587
1607
.
L. Lladó-Pelfort, P. Celada, M. S. Riga, E. Troyano-Rodríguez, N. Santana & F. Artigas. 2018. Behavioral Neurobiology of Psychedelic Drugs. Behavioral Neurobiology of Psychedelic Drugs
75
105
.
Xi-Ling Jiang, Hong-Wu Shen, Donald E. Mager, Stephan Schmidt & Ai-Ming Yu. (2016) Development of a mechanism-based pharmacokinetic/pharmacodynamic model to characterize the thermoregulatory effects of serotonergic drugs in mice. Acta Pharmaceutica Sinica B 6:5, pages 492-503.
Crossref
Crossref
Hande Sungur, Tilo Hartmann & Guido M. van Koningsbruggen. (2016) Abstract Mindsets Increase Believability of Spatially Distant Online Messages. Frontiers in Psychology 7.
Crossref
Crossref
Xi-Ling Jiang, Hong-Wu Shen & Ai-Ming Yu. (2016) Modification of 5-methoxy-N,N-dimethyltryptamine-induced hyperactivity by monoamine oxidase A inhibitor harmaline in mice and the underlying serotonergic mechanisms. Pharmacological Reports 68:3, pages 608-615.
Crossref
Crossref
Adam L. Halberstadt. (2016) Behavioral and pharmacokinetic interactions between monoamine oxidase inhibitors and the hallucinogen 5-methoxy-N,N-dimethyltryptamine. Pharmacology Biochemistry and Behavior 143, pages 1-10.
Crossref
Crossref
Curtis P. Snook. 2016. Critical Care Toxicology. Critical Care Toxicology
1
22
.
Steven Karch & Olaf Drummer. 2015. Karch's Pathology of Drug Abuse, Fifth Edition. Karch's Pathology of Drug Abuse, Fifth Edition
365
428
.
Ana Margarida Araújo, Félix Carvalho, Maria de Lourdes Bastos, Paula Guedes de Pinho & Márcia Carvalho. (2015) The hallucinogenic world of tryptamines: an updated review. Archives of Toxicology 89:8, pages 1151-1173.
Crossref
Crossref
Xi-Ling Jiang, Hong-Wu Shen & Ai-Ming Yu. (2015) Potentiation of 5-methoxy-N,N-dimethyltryptamine-induced hyperthermia by harmaline and the involvement of activation of 5-HT1A and 5-HT2A receptors. Neuropharmacology 89, pages 342-351.
Crossref
Crossref
Maurizio S. Riga, Guadalupe Soria, Raúl Tudela, Francesc Artigas & Pau Celada. (2014) The natural hallucinogen 5-MeO-DMT, component of Ayahuasca, disrupts cortical function in rats: reversal by antipsychotic drugs. The International Journal of Neuropsychopharmacology 17:08, pages 1269-1282.
Crossref
Crossref
Michael F. Santillo, Yitong Liu, Martine Ferguson, Sanah N. Vohra & Paddy L. Wiesenfeld. (2014) Inhibition of monoamine oxidase (MAO) by β-carbolines and their interactions in live neuronal (PC12) and liver (HuH-7 and MH1C1) cells. Toxicology in Vitro 28:3, pages 403-410.
Crossref
Crossref
Michael E. Nelson, Sean M. Bryant & Steven E. Aks. (2014) Emerging drugs of abuse. Disease-a-Month 60:3, pages 110-132.
Crossref
Crossref
David N. Khey, John Stogner & Bryan Lee MillerDavid N. Khey, John Stogner & Bryan Lee Miller. 2014. Emerging Trends in Drug Use and Distribution. Emerging Trends in Drug Use and Distribution
33
51
.
Xi-Ling Jiang, Hong-Wu Shen, Donald E. Mager & Ai-Ming Yu. (2013)
Pharmacokinetic Interactions between Monoamine Oxidase A Inhibitor Harmaline and 5-Methoxy-
N,N
-Dimethyltryptamine, and the Impact of CYP2D6 Status
. Drug Metabolism and Disposition 41:5, pages 975-986.
Crossref
Crossref
Shaun L. Greene. 2013. Novel Psychoactive Substances. Novel Psychoactive Substances
363
381
.
Victoria Hammiche, Rachida Merad & Mohamed AzzouzVictoria Hammiche, Rachida Merad & Mohamed Azzouz. 2013. Plantes toxiques à usage médicinal du pourtour méditerranéen. Plantes toxiques à usage médicinal du pourtour méditerranéen
137
149
.
Alain Gaujac, Sandro Navickiene, Mark I. Collins, Simon D. Brandt & Jailson Bittencourt Andrade. (2012) Analytical techniques for the determination of tryptamines and β-carbolines in plant matrices and in psychoactive beverages consumed during religious ceremonies and neo-shamanic urban practices. Drug Testing and Analysis 4:7-8, pages 636-648.
Crossref
Crossref
Adam L. Halberstadt, David E. Nichols & Mark A. Geyer. (2012) Behavioral effects of α,α,β,β-tetradeutero-5-MeO-DMT in rats: comparison with 5-MeO-DMT administered in combination with a monoamine oxidase inhibitor. Psychopharmacology 221:4, pages 709-718.
Crossref
Crossref
Donald G. Barceloux. 2012. Medical Toxicology of Drug Abuse. Medical Toxicology of Drug Abuse
768
780
.
Hong-Wu Shen, Xi-Ling Jiang & Ai-Ming Yu. (2011)
Nonlinear Pharmacokinetics of 5-Methoxy-
N,N
-dimethyltryptamine in Mice
. Drug Metabolism and Disposition 39:7, pages 1227-1234.
Crossref
Crossref
Hong-Wu Shen, Chao Wu, Xi-Ling Jiang & Ai-Ming Yu. (2010) Effects of monoamine oxidase inhibitor and cytochrome P450 2D6 status on 5-methoxy-N,N-dimethyltryptamine metabolism and pharmacokinetics. Biochemical Pharmacology 80:1, pages 122-128.
Crossref
Crossref
T. Herraiz, D. González, C. Ancín-Azpilicueta, V.J. Arán & H. Guillén. (2010) β-Carboline alkaloids in Peganum harmala and inhibition of human monoamine oxidase (MAO). Food and Chemical Toxicology 48:3, pages 839-845.
Crossref
Crossref
Chao Wu, Xi-Ling Jiang, Hong-Wu Shen & Ai-Ming Yu. (2009) Effects of CYP2D6 status on harmaline metabolism, pharmacokinetics and pharmacodynamics, and a pharmacogenetics-based pharmacokinetic model. Biochemical Pharmacology 78:6, pages 617-624.
Crossref
Crossref
Hong-Wu ShenXi-Ling JiangAi-Ming Yu. (2009)
Development of a LC–MS/MS method to analyze 5-methoxy-
N
,
N
-dimethyltryptamine and bufotenine: application to pharmacokinetic study
. Bioanalysis 1:1, pages 87-95.
Crossref
Crossref
Steven Karch. 2008. Karch's Pathology of Drug Abuse, Fourth Edition. Karch's Pathology of Drug Abuse, Fourth Edition
313
366
.
Adam L. Halberstadt, Mahalah R. Buell, Virginia L. Masten, Victoria B. Risbrough & Mark A. Geyer. (2008) Modification of the effects of 5-methoxy-N,N-dimethyltryptamine on exploratory behavior in rats by monoamine oxidase inhibitors. Psychopharmacology 201:1, pages 55-66.
Crossref
Crossref
Giampietro Frison, Donata Favretto, Flavio Zancanaro, Giorgio Fazzin & Santo Davide Ferrara. (2008) A case of β-carboline alkaloid intoxication following ingestion of Peganum harmala seed extract. Forensic Science International 179:2-3, pages e37-e43.
Crossref
Crossref
Kenneth W. Tupper. (2008) The globalization of ayahuasca: Harm reduction or benefit maximization?. International Journal of Drug Policy 19:4, pages 297-303.
Crossref
Crossref
Ai-Ming Yu. (2008) Indolealkylamines: Biotransformations and Potential Drug–Drug Interactions. The AAPS Journal 10:2.
Crossref
Crossref
Robert S. Gable. (2006) Risk assessment of ritual use of oral dimethyltryptamine (DMT) and harmala alkaloids. Addiction 102:1, pages 24-34.
Crossref
Crossref
JAWAID AKHTAR & JON C. RITTENBERGER. 2007. Haddad and Winchester's Clinical Management of Poisoning and Drug Overdose. Haddad and Winchester's Clinical Management of Poisoning and Drug Overdose
191
221
.
Kenji Tsujikawa, Hiroyuki Mohri, Kenji Kuwayama, Hajime Miyaguchi, Yuko Iwata, Akinaga Gohda, Sunao Fukushima, Hiroyuki Inoue & Tohru Kishi. (2006) Analysis of hallucinogenic constituents in Amanita mushrooms circulated in Japan. Forensic Science International 164:2-3, pages 172-178.
Crossref
Crossref
John H. Halpern & R. Andrew Sewell. (2005) Hallucinogenic botanicals of America: A growing need for focused drug education and research. Life Sciences 78:5, pages 519-526.
Crossref
Crossref
Michael Ganetsky & D. Eric Brush. (2005) Serotonin Syndrome—What Have We Learned?. Clinical Pediatric Emergency Medicine 6:2, pages 103-108.
Crossref
Crossref
Kavita M. Babu, Mary A. McCormick & Steven B. Bird. (2005) Pediatric Dietary Supplement Use—An Update. Clinical Pediatric Emergency Medicine 6:2, pages 85-92.
Crossref
Crossref
Kavita Babu, Edward W. Boyer, Christina Hernon & D. Eric Brush. (2005) Emerging Drugs of Abuse. Clinical Pediatric Emergency Medicine 6:2, pages 81-84.
Crossref
Crossref